We haven't done research lately into this company, but it might be time to investigate adding to our holdings. The current news seems to center on coronary stents, but the company has a number of other products which are useful in the cardiology and radiology interventional areas.Introducing new products is an FDA game, so we'll hope they have success there before their competitors.
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Rat